CASC15 is a marker of relapse in stage III melanoma patients.[84] The correlation of CASC15 expression level with shorter survival was based on RNA in situ hybridization in 141 formalin-fixed paraffin-embedded lymph node metastasis specimens. This evidence concerns the gene CASC15 and melanoma.